2.7
甲状腺腫とは、びまん性の甲状腺腫(均一な腫大)や結節状(単一または複数の結節)として現れる甲状腺の異常な腫大を指します。機能的には、無毒(正常/低ホルモンレベル)と有害(過剰なホルモン産生)に分類されます。
病態生理
びまん性甲状腺肥大は、甲状腺刺激ホルモン(TSH)やTSH様物質による長期的な刺激によ…
甲状腺腫とは甲状腺の異常な腫大です。広まって均一な腫れとして現れる場合もあれば、1つ以上の結節を持つ結節状の肥大として現れることもあります。
びまん性甲状腺腫は、甲状腺組織の慢性的な刺激によって引き起こされることが多く、TSH値の上昇、免疫媒介の活性化、ヨウ素欠乏などが原因となることがあります。
バセドウ病のような甲状腺機能亢進症では、甲状腺刺激免疫グロブリンと呼ばれる自己抗体がTSH受容体に結合し、過剰なホルモン産生を引き起こします。
甲状腺機能低下症では、橋本甲状腺炎やリチウムなどの特定の薬剤に見られるように、自己免疫による甲状腺破壊によりTSHが慢性的に上昇することがあります。
甲状腺ホルモン合成に影響を与える遺伝的欠陥も先天性甲状腺腫を引き起こすことがあります。
長期間の刺激により、びまん性甲状腺腫は徐々に結節状になり、最終的には自律的なホルモン産生を発達させ、毒性のある多節性甲状腺腫を引き起こすことがあります。甲状腺腫が拡大すると、隣接する構造に塊を及ぼし、呼吸困難や嚥下困難を引き起こすことがあります。
View the full transcript and gain access to JoVE Core videos
Q1: What causes diffuse goiter to develop?
Diffuse goiter results from prolonged thyroid stimulation, commonly due to elevated TSH levels, immune-mediated activation, or iodine deficiency. In hypothyroid conditions like Hashimoto's thyroiditis, chronic TSH elevation drives thyroid enlargement. Conversely, in hyperthyroid conditions such as Graves' disease, thyroid-stimulating immunoglobulins directly stimulate the gland, causing diffuse enlargement despite normal or low TSH levels.
Q2: How does iodine deficiency lead to goiter?
Iodine is essential for thyroid hormone synthesis. When daily intake falls below 100 micrograms, hormone production becomes impaired. The pituitary responds by increasing TSH secretion to compensate, stimulating thyroid tissue growth. Severe deficiency below 10 micrograms per day dramatically elevates TSH levels, causing significant thyroid hypertrophy and visible goiter enlargement.
Q3: What are goitrogens and how do they affect the thyroid?
Goitrogens are substances that interfere with thyroid hormone synthesis. Dietary sources include cabbage, cassava, and turnips, while environmental agents include perchlorate and thiocyanate. Medications such as lithium, propylthiouracil, and methimazole also act as goitrogens. Despite goitrogen exposure, individuals often remain euthyroid because compensatory TSH elevation maintains adequate hormone production.
Q4: How can diffuse goiter progress to toxic multinodular goiter?
Over prolonged stimulation, diffuse goiter may gradually become nodular as thyroid tissue develops heterogeneous growth patterns. Some nodules eventually acquire autonomous hormone production independent of TSH control. This progression, especially in older individuals and sometimes triggered by increased iodine intake, results in toxic multinodular goiter, where nodules produce excess thyroid hormones.
Q5: What compressive symptoms can large goiters cause?
As goiters enlarge, they exert mass effect on adjacent structures. Tracheal compression causes respiratory difficulty and breathing problems. Esophageal compression leads to dysphagia or trouble swallowing. Venous compression can cause facial flushing and neck vein distension. Pemberton's sign—facial flushing and venous engorgement upon arm elevation—indicates superior vena cava compression from a large goiter.
Q6: What is the difference between nontoxic and toxic goiter?
Nontoxic goiter involves thyroid enlargement with normal or low hormone levels, often resulting from iodine deficiency or goitrogen exposure. Toxic goiter produces excess thyroid hormones, as seen in Graves' disease or toxic multinodular goiter. Both types can appear diffuse or nodular, but functional classification depends on whether the enlarged gland produces abnormal hormone levels.
Q7: How do genetic defects contribute to congenital goiter?
Genetic defects affecting thyroid hormone synthesis enzymes can impair the production of thyroid hormones from birth. The fetal pituitary responds by elevating TSH levels to compensate for inadequate hormone production. This chronic fetal TSH stimulation drives thyroid tissue growth in utero, resulting in congenital goiter that is typically associated with hypothyroidism ii pathophysiology complications.